skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

8 Total results for product and free and sample content found

Medtech Insight: 世界の医療機器・医療技術の最新情報

US Election 2020: Industry Loses Three Favored Incumbents In Battle For Senate Control

A few of the US Senate candidates favored and given tens of thousands of dollars by industry have lost their battles for re-election

Topic us-election-2020 Legislation

Medtech Insight: 世界の医療機器・医療技術の最新情報

US Election 2020: Almost All House Members Backed By Industry PAC Dollars Retain Seats

Out of 31 US House incumbents supported by high amounts of medtech industry political action committee (PAC) dollars, only one – Chrissy Houlahan of Pennsylvania – lost in last week’s election.

Topic us-election-2020 policy-and-regulation Legislation

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Biopharma Needs A Deal On Drug Pricing As Shield Against Possible Democrat Wins - BIO's Greenwood

Outgoing Biotechnology Innovation Organization CEO suggests consideration of price inflation caps instead of 'big discounts' in Medicare Part D and says that industry should fund a cap on beneficiary out-of-pocket costs in the program.

Topic us-election-2020 drug-pricing Legislation

Medtech Insight: 世界の医療機器・医療技術の最新情報

All About Value – Brexit Aside, UK Industry Sees Good Things Ahead For Healthtech Adoption

ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.

Topic Medtech-Brexit EU Legislation Regulation

Generics Bulletin: ジェネリック&バイオシミラーニュース

California Plans To Create Own Generics Label

California’s 2020-2021 fiscal budget includes plans to work with manufacturers to establish the state’s own generics label. But industry is sceptical that the initiative will deliver the savings that the US state hopes for.

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Mylan/Biocon's Insulin Glargine Would Get A Respite Under US Budget Legislation

Bill addresses ‘dead zone’ for pending applications for protein products transitioning to biologic status; generic and brand industries each win in different legislative provisions: inclusion of the CREATES Act, and a revised definition for ‘biologics’ that includes chemically synthesized polypeptides.

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Outlook 2020 Report

Tap Outlook 2020’s essential coverage of medtech, R&D, clinical trials and regulation, manufacturing, and more with your extract from our most powerful report.

HBW Insight : コンシューマーヘルスケア産業のニュース

US Senate Passes First Monograph Reform Bill After House Passed Three

Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by the same title on its floor for a vote since it was passed by Energy and Commerce Committee in late June.

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。